News

Gaviscon maker is accused of rigging the market

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1121 (Published 24 February 2010) Cite this as: BMJ 2010;340:c1121
  1. Zosia Kmietowicz
  1. 1London

    The household products company Reckitt Benckiser UK is being investigated by the Office of Fair Trading (OFT) over whether it manipulated the market for its heartburn drug Gaviscon.

    The OFT alleges that the company sought to restrict competition to its Gaviscon brand of compound alginate preparations when it withdrew and delisted its Gaviscon Original Liquid from the NHS prescription channel in 2005 and introduced Gaviscon Advance, which was protected by …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe